Taken together, therefore, the data presented here suggest that potential roles for LMO2 in leukaemia may extend beyond its traditional function as a T-ALL oncogene, and at least in some patients involve activation of an early developmental HOX-LMO2 regulatory hierarchy. The gene discussed is LMO2; the disease is leukemia.